Lenalidomide

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product

Yes

Brand name base

Lenalidomide

Listing expiration

2027-12-31

Active Ingredients#

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

DailyMed Product Concepts#

Related Records#

• All packages for product NDC 82293-037
• DailyMed label: Lenalidomide
• FDA application 217281
• Company: Novugen Pharma (USA) LLC
• Search ingredient/name matches

Related UNII Ingredients#

DailyMed RxNorm Mappings#

Packages#

Related DailyMed Labels#